Correlation Between Europlasma and OSE Pharma

Can any of the company-specific risk be diversified away by investing in both Europlasma and OSE Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Europlasma and OSE Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Europlasma SA and OSE Pharma SA, you can compare the effects of market volatilities on Europlasma and OSE Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Europlasma with a short position of OSE Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Europlasma and OSE Pharma.

Diversification Opportunities for Europlasma and OSE Pharma

0.35

Correlation Coefficient

Europlasma  OSE Pharma

Weak diversification

The 3 months correlation between Europlasma and OSE is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Europlasma SA and OSE Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OSE Pharma SA and Europlasma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Europlasma SA are associated (or correlated) with OSE Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OSE Pharma SA has no effect on the direction of Europlasma i.e., Europlasma and OSE Pharma go up and down completely randomly.

Pair Corralation between Europlasma and OSE Pharma

Assuming the 90 days trading horizon Europlasma SA is expected to under-perform the OSE Pharma. In addition to that, Europlasma is 4.68 times more volatile than OSE Pharma SA. It trades about -0.01 of its total potential returns per unit of risk. OSE Pharma SA is currently generating about 0.07 per unit of volatility. If you would invest  325.00  in OSE Pharma SA on October 4, 2024 and sell it today you would earn a total of  428.00  from holding OSE Pharma SA or generate 131.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Europlasma SA  vs.  OSE Pharma SA

Europlasma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Europlasma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

OSE Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OSE Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Europlasma and OSE Pharma

The main advantage of trading using opposite Europlasma and OSE Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Europlasma position performs unexpectedly, OSE Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will offset losses from the drop in OSE Pharma's long position.

The idea behind Europlasma SA and OSE Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.